Systemic Therapy in Patients with LA-SCCHN: Current State and Unmet Needs
Learning Objectives
Upon completion of this program, participants will be able to:
- Recognize the care gaps and unmet need of patients with unresectable LA-SCCHN
- Describe alternative treatments for patients with unresectable LA-SCCHN and cisplatin ineligibility
- Summarize emerging therapies and investigational approaches for patients with unresectable LA-SCCHN
Speakers
Dr. Anna Spreafico
Course
This is a 60-minute MOC accredited program for Canadian Oncologists and other health care professionals. The goal is to raise awareness of head and neck cancers among Canadian Oncologists, with a focus on unmet needs in locally-advanced squamous cell carcinoma of the head and neck (LA-SCCHN), and agents under investigation.
Accreditation
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada, and approved by Queen’s University Office of CPD. You may claim a maximum of 0.75 hours (credits are automatically calculated.
This program has been made possible through unrestricted support from EMD Serono.
Studies/trials discussed:
- NRG-HN009 study
